Proteomic screening of a cell line model of esophageal carcinogenesis identifies cathepsin D and aldo-keto reductase 1C2 and 1B10 dysregulation in Barrett's esophagus and esophageal adenocarcinoma.

Proteomic screening of a cell line model of esophageal carcinogenesis identifies cathepsin D and aldo-keto reductase 1C2 and 1B10 dysregulation in Barrett's esophagus and esophageal adenocarcinoma.

Item
http://www.wikidata.org/entity/Q39994021
Risk factors for neoplastic progression in Barrett's esophagusExpression of aldo-keto reductase family 1 member b10 in the early stages of human hepatocarcinogenesisAldoketoreductase family 1B10 (AKR1B10) as a biomarker to distinguish hepatocellular carcinoma from benign liver lesionsProteomic identification of differentially-expressed proteins in esophageal cancer in three ethnic groups in Xinjiang.Analysis of synovial fluid in knee joint of osteoarthritis:5 proteome patterns of joint inflammation based on matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.Biomarkers of Barrett's esophagus.High Expression of Cathepsin E in Tissues but Not Blood of Patients with Barrett's Esophagus and AdenocarcinomaUp-regulated aldo-keto reductase family 1 member B10 in chronic hepatitis C: association with serum alpha-fetoprotein and hepatocellular carcinomaAldo-keto Reductase Family 1 Member B 10 Mediates Liver Cancer Cell Proliferation through Sphingosine-1-Phosphate.GERD-Barrett-Adenocarcinoma: Do We Have Suitable Prognostic and Predictive Molecular Markers?Promising anti-tumor properties of bisdemethoxycurcumin: A naturally occurring curcumin analogue.Expression, characterization and ligand specificity of lipocalin-1 interacting membrane receptor (LIMR).SILAC-based quantitative proteomic approach to identify potential biomarkers from the esophageal squamous cell carcinoma secretome.Aldo-keto reductase family 1 member B10 is associated with hepatitis B virus-related hepatocellular carcinoma risk.Aldo-Keto Reductase 1B10 and Its Role in Proliferation Capacity of Drug-Resistant CancersImpact of aldo-keto reductase family 1 member B10 on the risk of hepatitis C virus-related hepatocellular carcinoma.Evaluation of compound selectivity of aldo-keto reductases using differential scanning fluorimetry.
P2860

Proteomic screening of a cell line model of esophageal carcinogenesis identifies cathepsin D and aldo-keto reductase 1C2 and 1B10 dysregulation in Barrett's esophagus and esophageal adenocarcinoma.

Item
http://www.wikidata.org/entity/Q39994021
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Proteomic screening of a cell ...... and esophageal adenocarcinoma.
@en
Proteomic screening of a cell ...... and esophageal adenocarcinoma.
@en-gb
Proteomic screening of a cell ...... and esophageal adenocarcinoma.
@nl
type
label
Proteomic screening of a cell ...... and esophageal adenocarcinoma.
@en
Proteomic screening of a cell ...... and esophageal adenocarcinoma.
@en-gb
Proteomic screening of a cell ...... and esophageal adenocarcinoma.
@nl
prefLabel
Proteomic screening of a cell ...... and esophageal adenocarcinoma.
@en
Proteomic screening of a cell ...... and esophageal adenocarcinoma.
@en-gb
Proteomic screening of a cell ...... and esophageal adenocarcinoma.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Proteomic screening of a cell ...... and esophageal adenocarcinoma.
@en
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P921